Jelovsek, John Eric, Zhen Chen, Alayne D. Markland, Linda Brubaker, Keisha Y. Dyer, Susie Meikle, David D. Rahn, Nazeema Y. Siddiqui, Ashok Tuteja, and Matthew D. Barber. “Minimum important differences for scales assessing symptom severity and quality of life in patients with fecal incontinence..” Female Pelvic Med Reconstr Surg 20, no. 6 (November 2014): 342–48. https://doi.org/10.1097/SPV.0000000000000078.
John E Jelovsek, MD
Dr. Jelovsek is the Vice Chair of Education and the Director of Data Science for Women’s Health in Department of Obstetrics & Gynecology (OBGYN) at Duke University. He is Board Certified in OBGYN by the American Board of OBGYN and Board Certified in Female Pelvic Medicine & Reconstructive Surgery by the American Board of OBGYN and American Board of Urology. He currently practices Female Pelvic Medicine and Reconstructive Surgery (FPMRS). He has expertise in the development and validation of “individualized” patient-centered prediction tools to improve patient and clinician decision-making around development and possible prevention of pelvic floor disorders after childbirth, predicting the risk of de novo stress urinary incontinence after surgery for pelvic organ prolapse, wound infection after Cesarean delivery, transfusion during gynecologic surgery and efficacy and risk of undergoing pelvic organ prolapse surgery. These tools, although established in other fields, are innovative in the field of FPMRS and part of efforts to “individualize” medicine to patients with pelvic floor disorders by providing estimates of their risk for the conditions. He spends a significant proportion of time devoted to one on one mentoring of learners who are interested in learning how to build, code and test prediction models. He has significant clinical research experience as an investigator in the NICHD Pelvic Floor Disorders Network and most recently as part of the NIDDK Symptoms of Lower Urinary Tract Dysfunction Research Network (LURN).
Education and Training
- M.D., East Tennessee State University James H. Quillen College of Medicine, 1999
Selected Grants and Awards
Grimes, Cara L., Emily S. Lukacz, Marie G. Gantz, Lauren Klein Warren, Linda Brubaker, Halina M. Zyczynski, Holly E. Richter, et al. “What happens to the posterior compartment and bowel symptoms after sacrocolpopexy? evaluation of 5-year outcomes from E-CARE..” Female Pelvic Med Reconstr Surg 20, no. 5 (September 2014): 261–66. https://doi.org/10.1097/SPV.0000000000000085.
Unger, C. A., B. Ridgeway, J. E. Jelovsek, M. D. Barber, M. D. Walters, and M. F. Paraiso. “ADVERSE EVENTS ASSOCIATED WITH VAGINAL HYSTERECTOMY WITH HIGH UTEROSACRAL COLPOPEXY FOR UTEROVAGINAL PROLAPSE.” In Neurourology and Urodynamics, 33:816–17. WILEY, 2014.
Kow, Nathan, Mark D. Walters, Mickey M. Karram, Carlos J. Sarsotti, and J Eric Jelovsek. “Assessing intraoperative judgment using script concordance testing through the gynecology continuum of practice..” Med Teach 36, no. 8 (August 2014): 724–29. https://doi.org/10.3109/0142159X.2014.910297.
Unger, C. A., M. D. Barber, M. F. Paraiso, B. Ridgeway, M. D. Walters, and J. E. Jelovsek. “COMPARATIVE ESTIMATES OF LONG-TERM EFFECTIVENESS OF TRANSVAGINAL UTEROSACRAL COLPOPEXY VERSUS MINIMALLY INVASIVE SACRAL COLPOPEXY FOR THE TREATMENT OF PELVIC ORGAN PROLAPSE.” In Neurourology and Urodynamics, 33:822–23. WILEY-BLACKWELL, 2014.
Tunitsky-Bitton, E., A. M. Murphy, M. D. Barber, H. B. Goldman, S. Vasavada, and J. Jelovsek. “ASSESSMENT OF VOIDING AFTER SLING (AVAS): A RANDOMIZED TRIAL OF TWO METHODS OF POST-OPERATIVE CATHETER MANAGEMENT AFTER MIDURETHRAL SLING SURGERY FOR STRESS URINARY INCONTINENCE IN WOMEN.” In International Urogynecology Journal, 25:S2–3. SPRINGER LONDON LTD, 2014.
Tunitsky-Bitton, Elena, Cara R. King, Beri Ridgeway, Matthew D. Barber, Ted Lee, Tyler Muffly, Marie F. Paraiso, and J Eric Jelovsek. “Development and validation of a laparoscopic sacrocolpopexy simulation model for surgical training..” J Minim Invasive Gynecol 21, no. 4 (July 2014): 612–18. https://doi.org/10.1016/j.jmig.2013.12.124.
Jelovsek, J. “MODELS FOR PREDICTING RECURRENCE AND ADVERSE EVENTS AFTER PELVIC ORGAN PROLAPSE SURGERY.” In International Urogynecology Journal, 25:S58–59. SPRINGER LONDON LTD, 2014.